$0.327
-0.005 (-1.66%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de HRTX por análisis de gráficos similares
Alphio's HRTX stock price prediction model matches the current Heron Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.33 (-0.05%). The 1-week path is $0.32 (-0.97%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Heron Therapeutics Inc?
Heron Therapeutics Inc is not a good buy right now due to significant financial losses and legal challenges. The current price is $0.3266, and the company reported a net loss of $5.49 million in Q2 2026, which is a substantial increase from the previous year's loss of $2.38 million. Additionally, the stock has seen a year-to-date change of -74.08%, indicating a severe decline in value. The primary risk is the invalidation of key patents related to its main product, CINVANTI, which could lead to increased competition from generics and further financial instability.
HRTX cerró en $0.33 el Friday, tras bajar -1.66%
Heron Therapeutics Inc (HRTX) last closed at $0.3266, losing -1.66%. These facts feed the 1-day and 1-week HRTX price prediction above.
Consenso de analistas
Heron Therapeutics Inc (HRTX): 11 comprar, 0 mantener, 0 vender. Perspectiva: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Factores de la previsión
Los factores de la previsión de Heron Therapeutics Inc (HRTX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de HRTX, ordenadas por similitud.
Análisis de estacionalidad de HRTX
Historically the probability of a positive August return for HRTX is 38.10%. February offers the highest probability of a positive month at 75.86%, while November is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de HRTX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $2.17 | $2.24 | $2.47 | +584.96% |
| Sep 2026 | $2.01 | $2.31 | $2.35 | +608.38% |
| Oct 2026 | $1.91 | $2.22 | $2.53 | +580.32% |
| Nov 2026 | $2.29 | $2.32 | $2.43 | +610.32% |
| Dec 2026 | $1.66 | $1.91 | $2.09 | +484.76% |
En 2026, se proyecta que Heron Therapeutics Inc (HRTX) oscile entre $1.66 y $2.53.
Previsión mensual de Heron Therapeutics Inc para 2026
En Aug de 2026, se proyecta que Heron Therapeutics Inc promedie $2.24, con un mínimo de $2.17 y un máximo de $2.47.
En Sep de 2026, se proyecta que Heron Therapeutics Inc promedie $2.31, con un mínimo de $2.01 y un máximo de $2.35.
En Oct de 2026, se proyecta que Heron Therapeutics Inc promedie $2.22, con un mínimo de $1.91 y un máximo de $2.53.
En Nov de 2026, se proyecta que Heron Therapeutics Inc promedie $2.32, con un mínimo de $2.29 y un máximo de $2.43.
En Dec de 2026, se proyecta que Heron Therapeutics Inc promedie $1.91, con un mínimo de $1.66 y un máximo de $2.09.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.